Prevention of primary nonfunction of xenograft islets.
Department of Surgery, University Medical Center, Greenville, North Carolina 27858.
K
K
Pittman
J
J
Henretta
T
T
McFadden
J
J
Thomas
F T
FT
Thomas
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000601:surgery*; D006085:Graft Survival / Q000276:immunology*; D006146:Guanidines / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016381:Islets of Langerhans Transplantation / Q000502:physiology*; D051381:Rats; D011917:Rats, Inbred Lew; D013552:Swine; D014183:Transplantation, Heterologous / Q000502:physiology*
D000961:Antilymphocyte Serum; D001786:Blood Glucose; D006146:Guanidines; D007166:Immunosuppressive Agents; C037258:gusperimus